Recent developments of liposomes as nanocarriers for theranostic applications

Hang Xing, Kevin Hwang, Yi Lu

Research output: Contribution to journalReview article

Abstract

Liposomes are nanocarriers comprised of lipid bilayers encapsulating an aqueous core. The ability of liposomes to encapsulate a wide variety of diagnostic and therapeutic agents has led to significant interest in utilizing liposomes as nanocarriers for theranostic applications. In this review, we highlight recent progress in developing liposomes as nanocarriers for a) diagnostic applications to detect proteins, DNA, and small molecule targets using fluorescence, magnetic resonance, ultrasound, and nuclear imaging; b) therapeutic applications based on small molecule-based therapy, gene therapy and immunotherapy; and c) theranostic applications for simultaneous detection and treatment of heavy metal toxicity and cancers. In addition, we summarize recent studies towards understanding of interactions between liposomes and biological components. Finally, perspectives on future directions in advancing the field for clinical translations are also discussed.

Original languageEnglish (US)
Pages (from-to)1336-1352
Number of pages17
JournalTheranostics
Volume6
Issue number9
DOIs
StatePublished - Jan 1 2016

Fingerprint

Liposomes
Lipid Bilayers
Therapeutics
Genetic Therapy
Immunotherapy
Ultrasonography
Magnetic Resonance Spectroscopy
Fluorescence
Theranostic Nanomedicine
DNA
Neoplasms
Proteins

Keywords

  • Clinical translation
  • Liposomes
  • Multimodal imaging
  • Targeted therapy
  • Theranostics

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Cite this

Recent developments of liposomes as nanocarriers for theranostic applications. / Xing, Hang; Hwang, Kevin; Lu, Yi.

In: Theranostics, Vol. 6, No. 9, 01.01.2016, p. 1336-1352.

Research output: Contribution to journalReview article

Xing, Hang ; Hwang, Kevin ; Lu, Yi. / Recent developments of liposomes as nanocarriers for theranostic applications. In: Theranostics. 2016 ; Vol. 6, No. 9. pp. 1336-1352.
@article{ac871f9e935444e3ad979be64e1bee6b,
title = "Recent developments of liposomes as nanocarriers for theranostic applications",
abstract = "Liposomes are nanocarriers comprised of lipid bilayers encapsulating an aqueous core. The ability of liposomes to encapsulate a wide variety of diagnostic and therapeutic agents has led to significant interest in utilizing liposomes as nanocarriers for theranostic applications. In this review, we highlight recent progress in developing liposomes as nanocarriers for a) diagnostic applications to detect proteins, DNA, and small molecule targets using fluorescence, magnetic resonance, ultrasound, and nuclear imaging; b) therapeutic applications based on small molecule-based therapy, gene therapy and immunotherapy; and c) theranostic applications for simultaneous detection and treatment of heavy metal toxicity and cancers. In addition, we summarize recent studies towards understanding of interactions between liposomes and biological components. Finally, perspectives on future directions in advancing the field for clinical translations are also discussed.",
keywords = "Clinical translation, Liposomes, Multimodal imaging, Targeted therapy, Theranostics",
author = "Hang Xing and Kevin Hwang and Yi Lu",
year = "2016",
month = "1",
day = "1",
doi = "10.7150/thno.15464",
language = "English (US)",
volume = "6",
pages = "1336--1352",
journal = "Theranostics",
issn = "1838-7640",
publisher = "Ivyspring International Publisher",
number = "9",

}

TY - JOUR

T1 - Recent developments of liposomes as nanocarriers for theranostic applications

AU - Xing, Hang

AU - Hwang, Kevin

AU - Lu, Yi

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Liposomes are nanocarriers comprised of lipid bilayers encapsulating an aqueous core. The ability of liposomes to encapsulate a wide variety of diagnostic and therapeutic agents has led to significant interest in utilizing liposomes as nanocarriers for theranostic applications. In this review, we highlight recent progress in developing liposomes as nanocarriers for a) diagnostic applications to detect proteins, DNA, and small molecule targets using fluorescence, magnetic resonance, ultrasound, and nuclear imaging; b) therapeutic applications based on small molecule-based therapy, gene therapy and immunotherapy; and c) theranostic applications for simultaneous detection and treatment of heavy metal toxicity and cancers. In addition, we summarize recent studies towards understanding of interactions between liposomes and biological components. Finally, perspectives on future directions in advancing the field for clinical translations are also discussed.

AB - Liposomes are nanocarriers comprised of lipid bilayers encapsulating an aqueous core. The ability of liposomes to encapsulate a wide variety of diagnostic and therapeutic agents has led to significant interest in utilizing liposomes as nanocarriers for theranostic applications. In this review, we highlight recent progress in developing liposomes as nanocarriers for a) diagnostic applications to detect proteins, DNA, and small molecule targets using fluorescence, magnetic resonance, ultrasound, and nuclear imaging; b) therapeutic applications based on small molecule-based therapy, gene therapy and immunotherapy; and c) theranostic applications for simultaneous detection and treatment of heavy metal toxicity and cancers. In addition, we summarize recent studies towards understanding of interactions between liposomes and biological components. Finally, perspectives on future directions in advancing the field for clinical translations are also discussed.

KW - Clinical translation

KW - Liposomes

KW - Multimodal imaging

KW - Targeted therapy

KW - Theranostics

UR - http://www.scopus.com/inward/record.url?scp=84991627514&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991627514&partnerID=8YFLogxK

U2 - 10.7150/thno.15464

DO - 10.7150/thno.15464

M3 - Review article

C2 - 27375783

AN - SCOPUS:84991627514

VL - 6

SP - 1336

EP - 1352

JO - Theranostics

JF - Theranostics

SN - 1838-7640

IS - 9

ER -